New study aims to find best Non-Invasive liver test for cystic fibrosis kids

NCT ID NCT02342964

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared four non-invasive methods—FibroTest, Fibroscan, ShearWave Elastography, and Magnetic Resonance Elastography—to measure liver fibrosis in 56 children with cystic fibrosis aged 6-18. The goal was to see which test best detects early liver damage, helping doctors decide when to start treatment with ursodeoxycholic acid to prevent cirrhosis. The study is complete, but results are not yet widely available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors choose the best non-invasive test to detect liver fibrosis early in cystic fibrosis, potentially slowing disease progression with timely treatment.
What could go wrong
This is a small, completed study with only 56 participants, so results may not apply to all patients. The tests are compared to each other, not to a gold standard, so accuracy remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Necker

    Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.